- Record: found
- Abstract: found
- Article: not found
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
C H Schenck
1 ,
J Y Montplaisir ,
B Frauscher ,
B Hogl ,
J-F Gagnon ,
R Postuma ,
K Sonka ,
P Jennum ,
M Partinen ,
I Arnulf ,
V Cochen de Cock ,
Y Dauvilliers ,
P-H Luppi ,
A Heidbreder ,
G Mayer ,
F Sixel-Döring ,
C Trenkwalder ,
M Unger ,
P Young ,
Y K Wing ,
L Ferini-Strambi ,
R Ferri ,
G Plazzi ,
M Zucconi ,
Y Inoue ,
A Iranzo ,
J Santamaria ,
C Bassetti ,
J C Möller ,
B F Boeve ,
Y Y Lai ,
M Pavlova ,
C Saper ,
P Schmidt ,
J M Siegel ,
C Singer ,
E St Louis ,
A Videnovic ,
W Oertel
Aug 2013
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We aimed to provide a consensus statement by the International Rapid Eye Movement Sleep Behavior Disorder Study Group (IRBD-SG) on devising controlled active treatment studies in rapid eye movement sleep behavior disorder (RBD) and devising studies of neuroprotection against Parkinson disease (PD) and related neurodegeneration in RBD.